Guardant Health, Inc. (GH) Financials
GH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.8 billion | 1.6 billion |
2023-09-30 | 1.8 billion | 1.6 billion |
2023-06-30 | 1.8 billion | 1.5 billion |
2023-03-31 | 1.5 billion | 1.6 billion |
GH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -82.8 million | 24.3 million |
2023-09-30 | -80.2 million | 21.8 million |
2023-06-30 | -100.5 million | 22.4 million |
2023-03-31 | -82.0 million | 22.3 million |
GH Net Income
No data available :(
GH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.2 billion | - | 213.8 million |
2023-09-30 | 1.2 billion | - | 219.0 million |
2023-06-30 | 1.2 billion | 1.1 billion | 198.2 million |
2023-03-31 | 937.0 million | 1.1 billion | 204.9 million |
GH Shares Outstanding
GH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 4.1 million | 89.9 million | 37.7 million | 79.1 million |
2023-09-30 | 2.4 million | 93.9 million | 36.2 million | 68.9 million |
2023-06-30 | 6.5 million | 90.4 million | 41.5 million | 71.0 million |
2023-03-31 | 7.5 million | 93.1 million | 40.4 million | 76.1 million |
GH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 155.1 million | -81.1 million |
2023-09-30 | 143.0 million | 57.6 million |
2023-06-30 | 137.2 million | 53.8 million |
2023-03-31 | 128.7 million | 53.1 million |
GH
Price: $18.88
52 week price:
Earnings Per Share: -4.28 USD
P/E Ratio: -5.56
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 409714
Market Capitalization: 2.2 billion